Pharmacoinvasive Approach with Streptokinase in Low to Intermediate Risk ST-Elevation Myocardial Infarction Patients: Insights from the Tamil Nadu-STEMI Initiative

American Journal of Cardiovascular Drugs - Tập 19 - Trang 517-519 - 2019
Dharam J. Kumbhani1, Thomas Alexander2, Brahmajee K. Nallamothu3, Venu Menon4, Colby Ayers1, Ajit S. Mullasari5
1Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, USA
2Kovai Medical Center and Hospital, Coimbatore, India
3University of Michigan, North Campus Research Complex, Ann Arbor, USA
4Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, USA.
5Madras Medical Mission Hospital, Chennai, India

Tài liệu tham khảo

Pinto DS, Kirtane AJ, Nallamothu BK, Murphy SA, Cohen DJ, Laham RJ, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114:2019–25. American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78–140. Nallamothu BK, Bates ER, Wang Y, Bradley EH, Krumholz HM. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation. 2006;113:1189–95. Schiele F, Hochadel M, Tubaro M, Meneveau N, Wojakowski W, Gierlotka M, et al. Reperfusion strategy in Europe: temporal trends in performance measures for reperfusion therapy in ST-elevation myocardial infarction. Eur Heart J. 2010;31:2614–24. Nallamothu BK. A race for the base: ST-segment-elevation myocardial infarction systems of care in low- and middle-income countries. Circ Cardiovasc Qual Outcomes. 2013;6:5–6. Kaifoszova Z, Kala P, Alexander T, Zhang Y, Huo Y, Snyders A, et al. Stent for Life Initiative: leading example in building STEMI systems of care in emerging countries. EuroIntervention. 2014;10 Suppl T:T87–95. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360:2705–18. Alexander T, Mullasari AS, Joseph G, Kannan K, Veerasekar G, Victor SM, et al. A system of care for patients with ST-segment elevation myocardial infarction in India: the Tamil Nadu-ST-Segment Elevation Myocardial Infarction Program. JAMA Cardiol. 2017;2:498–505. Mishra S. What is the ideal fibrinolysis to PCI time: pharmaco-invasive strategy with streptokinase? Indian Heart J. 2017;69:569–70. Mishra S, Ramakrishnan S, Babu AS, Roy A, Bahl VK, Singru KV, et al. Management algorithms for acute ST elevation myocardial infarction in less industrialized world. Indian Heart J. 2017;69(Suppl 1):S98–103. Fitzgerald DJ, Catella F, Roy L, FitzGerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142–50. Vaughan DE, Van Houtte E, Declerck PJ, Collen D. Streptokinase-induced platelet aggregation. Prevalence and mechanism. Circulation. 1991;84:84–91.